Women's Health

Women who initiated endoscopy screening before age 50 years demonstrated a significantly reduced risk for colorectal cancer than women who did not undergo endoscopy, according to study results published in JAMA Oncology.

After 2 consecutive years of virtual conferences, ACOG is back to hosting its Annual Clinical & Scientific Meeting in person.

The addition of ribociclib to fulvestrant conferred a survival benefit of nearly 16 months as first-line treatment for postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer, topline data showed.

The FDA granted fast track designation to ofranergene obadenovec in combination with paclitaxel for treatment of platinum-resistant ovarian cancer.

CHICAGO — In this video interview with Healio, Stephanie Faubion, MD, MBA, FACP, NCMP, IF, highlights recent research on women’s health, which she discussed during her presentation here.

CHICAGO — Heart disease is a leading health threat for women, according to C. Noel Bairey Merz, MD, FACC, FAHA, FESC, the director of the Barbra Streisand Women’s Heart Institute at Cedars-Sinai.

Reported menopause symptoms and prescriptions for hormone therapy were less common among Black and Hispanic female veterans, highlighting disparities in the discussion, documentation and management of menopause, according to researchers.

The FDA granted breakthrough therapy designation to fam-trastuzumab deruxtecan-nxki for treatment of adults with unresectable or metastatic HER2-low breast cancer, according to a press release from the agent’s manufacturer.

Black/African American and Hispanic/Latina women who have low vitamin D concentrations may be more likely to be diagnosed with breast cancer than those with adequate concentrations, according to a study published in Cancer.

Among people with a previous SARS-CoV-2 infection, women were more symptomatic than men — not just in the acute phase but also months later — according to a retrospective prospective study in the Journal of Women’s Health.